相关实验视频
Updated: Jun 17, 2025

06:35
Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 24, 2010
16.8K
阿尔茨海默病神经成像计划的临床核心
Paul S Aisen1, Michael C Donohue1, Rema Raman1
1Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA.
概括
自2004年以来,阿尔茨海默氏病神经成像计划 (ADNI) 临床核心已经管理了2400多名参与者. ADNI数据显著提升了我们对阿尔茨海默病进展的理解,并改善了临床试验设计.
科学领域:
- 神经成像和临床研究
- 阿尔茨海默病的进展 疾病的进展
- 临床试验设计 临床试验设计
背景情况:
- 阿尔茨海默病神经成像计划 (ADNI) 临床核心协调阿尔茨海默病研究的临床活动和数据管理.
- 自ADNI成立以来,已经招募了2400多名具有不同认知状态的参与者.
研究的目的:
- 描述阿尔茨海默病 (AD) 队列的横截面和纵向特征.
- 为AD治疗的临床试验设计提供信息.
- 改进对阿尔茨海默病从症状前阶段到痴呆症的发展轨迹的理解.
主要方法:
- 协调ADNI各站点的临床活动,包括项目管理,监管监督和数据收集.
- 开发AD试验的临床分类和招生标准.
- 纵向数据分析以跟踪认知和临床变化.
主要成果:
- 在正常认知,轻度认知障碍和轻度AD痴呆症中招募了2400多名参与者.
- 阐明了AD的完整认知和临床轨迹.
- ADNI数据在设计主要的AD治疗试验中发挥了重要作用.
结论:
- ADNI临床核心的努力为了解AD提供了一个强大的数据集.
- 来自ADNI的纵向数据有助于在整个疾病谱中建模治疗试验.
- ADNI数据对阿尔茨海默病研究和药物开发领域产生了重大影响.
相关概念视频
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Brain Imaging
219
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
219
Imaging Studies II: Positron Emission Tomography and Scintigraphy
99
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
99
Imaging Studies I: CT and MRI
209
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
209
Magnetic Resonance Imaging
5.0K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.0K

